Director at Inhibikase (NASDAQ: IKT) receives 155K stock options grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Inhibikase Therapeutics, Inc. director Amit Munshi reported a compensation-related grant of stock options. He received options to acquire 155,000 shares of common stock at an exercise price of $1.91 per share, with no cash paid for the grant itself.
The options vest on the earlier of June 26, 2027 or the day before the next annual meeting of stockholders, conditioned on his continued service as a director through that date. After this grant, his reported stock option holdings from this award total 155,000 options, which are scheduled to expire on June 26, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Munshi Amit
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 155,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 155,000 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 155,000 options
Exercise price: $1.91 per share
Post-grant option holdings: 155,000 options
+2 more
5 metrics
Options granted
155,000 options
Stock Option (Right to Buy) grant to director
Exercise price
$1.91 per share
Stock option exercise price for common stock
Post-grant option holdings
155,000 options
Total options following this reported grant
Vesting date
June 26, 2027
Vests earlier of this date or day before next annual meeting
Expiration date
June 26, 2036
Option expiration for this 155,000-share grant
Key Terms
Stock Option (Right to Buy), exercise price, annual meeting of stockholders, vest, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 1.9100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
annual meeting of stockholders financial
"the day prior to the next annual meeting of stockholders"
vest financial
"The options will vest on the earlier of June 26, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
expiration date financial
"expiration_date: 2036-06-26T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What did Amit Munshi report in this Inhibikase (IKT) Form 4 filing?
Amit Munshi reported receiving a grant of stock options for 155,000 shares of Inhibikase common stock. These options are a compensation-related award, not an open-market purchase or sale of existing shares.
How many Inhibikase (IKT) stock options were granted to Amit Munshi?
He was granted stock options covering 155,000 shares of Inhibikase common stock. This entire amount is tied to a single award reported in the filing, with all 155,000 options outstanding following the transaction.
What is the exercise price of Amit Munshi’s Inhibikase (IKT) options?
The stock options have an exercise price of $1.91 per share. This is the price at which he can purchase Inhibikase common shares in the future if the options vest and are exercised.
When do Amit Munshi’s Inhibikase (IKT) options vest?
The options vest on the earlier of June 26, 2027 or the day prior to the next annual meeting of stockholders. Vesting depends on his continued service as a director through the applicable vesting date.
When do Amit Munshi’s Inhibikase (IKT) stock options expire?
The options are scheduled to expire on June 26, 2036. After that expiration date, any unexercised portion of the 155,000-share option grant can no longer be exercised for Inhibikase common stock.